-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The Production Process of 3-(2-methylpyrimidin-4-yl)pyrrolidin-3-ol: An Overview in the Chemical Industry
3-(2-methylpyrimidin-4-yl)pyrrolidin-3-ol, also known as MAPK-12, is a synthetic compound that has been widely studied for its potential therapeutic properties.
This compound is known to exhibit a wide range of biological activities, including anti-inflammatory, analgesic, and anticancer effects.
As a result, there is significant interest in the development of efficient and cost-effective methods for the production of MAPK-12.
In this article, we will provide an overview of the production process of MAPK-12, highlighting the key steps involved in the manufacturing process and the chemical reactions that take place.
Step 1: Synthesis of 4-chloro-2-methylpyrimidine
The synthesis of 4-chloro-2-methylpyrimidine is the first step in the production of MAPK-12.
This compound can be synthesized using various methods, with one of the most common methods being the reaction of chloroacetamide with formaldehyde in the presence of a strong acid catalyst.
The reaction produces 4-chloro-2-methylpyrimidine, which is then purified by chromatography.
Step 2: Synthesis of 2-methylpyrimidine-4-boronic acid
In the second step of the production process, 4-chloro-2-methylpyrimidine is converted into 2-methylpyrimidine-4-boronic acid.
The synthesis of this compound involves the reaction of 4-chloro-2-methylpyrimidine with boronic acid in the presence of a Lewis acid catalyst, such as zinc chloride or aluminum chloride.
The reaction produces 2-methylpyrimidine-4-boronic acid, which can then be purified by chromatography.
Step 3: Synthesis of 3-(2-methylpyrimidin-4-yl)pyrrolidin-3-ol
The final step in the production of MAPK-12 involves the synthesis of the target compound itself, 3-(2-methylpyrimidin-4-yl)pyrrolidin-3-ol.
This synthesis involves the reaction of 2-methylpyrimidine-4-boronic acid with pyrrolidine-3-boronic acid in the presence of a transition metal catalyst, such as ruthenium or osmium.
The reaction produces 3-(2-methylpyrimidin-4-yl)pyrrolidin-3-ol, which can then be purified by chromatography.
Challenges and Opportunities
The synthesis of MAPK-12 involves several challenging steps, including the synthesis of the key intermediate compounds 4-chloro-2-methylpyrimidine and 2-methylpyrimidine-4-boronic acid.
These steps require careful attention to reaction conditions and purification protocols to ensure the production of high-purity intermediates.
Additionally, the synthesis of MAPK-12 requires the use of expensive and rare metal catalysts, such as ruthenium or osmium, which can significantly impact the cost and efficiency of the production process.
Despite these challenges, there are significant opportunities for the development of new and more efficient methods for the production of MAPK-12.
For example, researchers are actively exploring the use of alternative synthesis routes, such as the use of microwave-assisted synthesis, which has been